{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:30:32Z","timestamp":1776288632151,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijgc.2024.100019","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T09:19:42Z","timestamp":1735636782000},"page":"100019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of clinical and laboratory variables with risk of venous thromboembolism in high-grade serous ovarian cancer"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5414-4603","authenticated-orcid":false,"given":"Maija H.","family":"Peippo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3812-0871","authenticated-orcid":false,"given":"Katariina","family":"Perkonoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veli-Matti","family":"Isoviita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0854-7225","authenticated-orcid":false,"given":"Johanna","family":"Hynninen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olli","family":"Carp\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijgc.2024.100019_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100019_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000363","article-title":"Real-world features associated with cancer-related venous thromboembolic events","volume":"3","author":"Peippo","year":"2018","journal-title":"ESMO Open"},{"issue":"8","key":"10.1016\/j.ijgc.2024.100019_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/ijgc-2024-005735","article-title":"Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients","volume":"34","author":"Lampert","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2024.100019_bib4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/IGC.0b013e3182a80aa7","article-title":"Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer","volume":"23","author":"Mokri","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100019_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000001980","article-title":"Incidence and timing of thromboembolic events in patients with ovarian cancer undergoing neoadjuvant chemotherapy","volume":"129","author":"Greco","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100019_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3802\/jgo.2013.24.1.52","article-title":"Effect of ovarian tumor characteristics on venous thromboembolic risk","volume":"24","author":"Bakhru","year":"2013","journal-title":"J Gynecol Oncol"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2024.100019_bib7","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.thromres.2018.01.028","article-title":"Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer","volume":"164","author":"Lyman","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijgc.2024.100019_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.thromres.2017.07.025","article-title":"Late consequences of venous thromboembolism: measuring quality of life after deep vein thrombosis and pulmonary embolism","volume":"164","author":"Ghanima","year":"2018","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.ijgc.2024.100019_bib9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/aogs.14246","article-title":"Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: a retrospective study","volume":"100","author":"Oxley","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100019_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ygyno.2007.05.040","article-title":"Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer","volume":"107","author":"Black","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100019_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2012.08.032","article-title":"Prolonged postoperative venous thrombo-embolism prophylaxis is cost-effective in advanced ovarian cancer patients","volume":"127","author":"Uppal","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ijgc.2024.100019_bib12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/jamaoncol.2023.3634","article-title":"Risk-Directed Ambulatory thromboprophylaxis in Lung and gastrointestinal Cancers: the TARGET-TP Randomized Clinical Trial","volume":"9","author":"Alexander","year":"2023","journal-title":"JAMA Oncol"},{"issue":"25","key":"10.1016\/j.ijgc.2024.100019_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007062","article-title":"Clinical significance of plasma D-dimer in ovarian cancer: a meta-analysis","volume":"96","author":"Wu","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100019_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejogrb.2013.06.004","article-title":"Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival","volume":"170","author":"Abu Saadeh","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100019_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ejso.2020.01.026","article-title":"Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period","volume":"46","author":"Zhou","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2024.100019_bib16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, Lung, or ovarian cancer: the prospective COMPASS\u2013cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100019_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2017.04.021","article-title":"Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer","volume":"146","author":"Cohen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2024.100019_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00132","article-title":"Open source infrastructure for health care data integration and machine learning analyses","volume":"3","author":"Isoviita","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"issue":"10","key":"10.1016\/j.ijgc.2024.100019_bib19","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100019_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/0284186X.2019.1679881","article-title":"CA 19\u20139 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study","volume":"59","author":"Peippo","year":"2020","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100019_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2024.100019_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100019_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/ijgc-2023-005166","article-title":"Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis","volume":"34","author":"Black","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2024.100019_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2374716","article-title":"Meta-analysis of VTE risk: ovarian cancer patients by stage, histology, cytoreduction, and ascites at diagnosis","volume":"2020","author":"Weeks","year":"2020","journal-title":"Obstet Gynecol Int"},{"issue":"50","key":"10.1016\/j.ijgc.2024.100019_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002316","article-title":"Pattern of venous thromboembolism occurrence in gynecologic malignancy: incidence, timing, and distribution a 10-year retrospective single-institutional study","volume":"94","author":"Ye","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.ijgc.2024.100019_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2024.02.011","article-title":"Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database","volume":"185","author":"Penfound","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ijgc.2024.100019_bib27","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jogc.2021.05.010","article-title":"Venous thromboembolism in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer and impact on survival","volume":"43","author":"Black","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"issue":"7","key":"10.1016\/j.ijgc.2024.100019_bib28","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cam4.4397","article-title":"Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer","volume":"11","author":"Eurola","year":"2022","journal-title":"Cancer Med"},{"issue":"14","key":"10.1016\/j.ijgc.2024.100019_bib29","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100019_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","article-title":"Chemotherapy-induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100019_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.ijgc.2024.100019_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ejca.2010.02.012","article-title":"Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy","volume":"46","author":"Han","year":"2010","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100019_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/IGC.0b013e31827b8796","article-title":"Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer","volume":"23","author":"Tas","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100019_bib34","first-page":"129","article-title":"The combination of D-dimer and Glasgow prognostic score can be useful in predicting VTE in patients with stage IIIC and IVA ovarian cancer","volume":"76","author":"Kubo","year":"2022","journal-title":"Acta Med Okayama"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100019_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:59:26Z","timestamp":1740545966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24014907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1048891X24014907"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2024.100019","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of clinical and laboratory variables with risk of venous thromboembolism in high-grade serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2024.100019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"100019"}}